Signaling cascades of Pasteurella multocida toxin in immune evasion

Toxins

Volumn 5, Issue 9, 2013, Pages 1664-1681

  Kubatzky, Katharina F ^a   Kloos, Bianca ^a   Hildebrand, Dagmar ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Bacterial toxin; Carcinogenesis; Immune evasion; Osteoclast; Osteoimmunology; Pasteurella multocida; Signal transduction

Indexed keywords

BACTERIAL TOXIN; CARCINOGEN; PASTEURELLA MULTOCIDA TOXIN; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL COUNT; CELL DIFFERENTIATION; CELL TRANSFORMATION; IMMUNE EVASION; IMMUNOCOMPETENT CELL; INFLAMMATION; NEOPLASM; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PASTEURELLA MULTOCIDA; PORCINE ATROPHIC RHINITIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BONE AND BONES; HUMANS; IMMUNE EVASION; NEOPLASMS; PASTEURELLA MULTOCIDA; SIGNAL TRANSDUCTION;

EID: 84884994065     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins5091664     Document Type: Review

References (101)

1. Wilkie, I.W.; Harper, M.; Boyce, J.D.; Adler, B. Pasteurella multocida: Diseases and pathogenesis. Curr. Top. Microbiol. Immunol. 2012, 361, 1-22.
2. Amigot, J.A.; Torremorell, M.; Pijoan, C. Evaluation of techniques for the detection of toxigenic Pasteurella multocida strains from pigs. J. Vet. Diagn. Investig. 1998, 10, 169-173.
3. Martineau-Doize, B.; Frantz, J.C.; Martineau, G.P. Effects of purified Pasteurella multocida dermonecrotoxin on cartilage and bone of the nasal ventral conchae of the piglet. Anat. Rec. 1990, 228, 237-246.
4. Horiguchi, Y. Swine atrophic rhinitis caused by Pasteurella multocida toxin and bordetella dermonecrotic toxin. Curr. Top. Microbiol. Immunol. 2012, 361, 113-129.
5. De Jong, M.F.; Nielsen, J.P. Definition of progressive atrophic rhinitis. Vet. Rec. 1990, 126, 93.
6. Nakai, T.; Sawata, A.; Tsuji, M.; Kume, K. Characterization of dermonecrotic toxin produced by serotype D strains of Pasteurella multocida. Am. J. Vet. Res. 1984, 45, 2410-2413.
7. Kubatzky, K.F. Pasteurella multocida and immune cells. Curr. Top. Microbiol. Immunol. 2012, 361, 53-72.
8. Sansonetti, P. Host-pathogen interactions: The seduction of molecular cross talk. Gut 2002, doi:10.1136/gut.50.suppl_3.iii2.
9. Barth, K.; Remick, D.G.; Genco, C.A. Disruption of immune regulation by microbial pathogens and resulting chronic inflammation. J. Cell. Physiol. 2013, 228, 1413-1422.
10. Coombes, B.K.; Valdez, Y.; Finlay, B.B. Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses. Curr. Biol. 2004, 14, R856-R867.
11. Finlay, B.B.; McFadden, G. Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens. Cell 2006, 124, 767-782.
12. Repella, T.L.; Ho, M.; Chong, T.P.; Bannai, Y.; Wilson, B.A. Arf6-dependent intracellular trafficking of Pasteurella multocida toxin and pH-dependent translocation from late endosomes. Toxins 2011, 3, 218-241.
13. Orth, J.H.; Preuss, I.; Fester, I.; Schlosser, A.; Wilson, B.A.; Aktories, K. Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation. Proc. Natl. Acad. Sci. USA 2009, 106, 7179-7184.
14. Orth, J.H.; Fester, I.; Siegert, P.; Weise, M.; Lanner, U.; Kamitani, S.; Tachibana, T.; Wilson, B.A.; Schlosser, A.; Horiguchi, Y.; et al. Substrate specificity of Pasteurella multocida toxin for alpha subunits of heterotrimeric G proteins. FASEB J. 2013, 27, 832-842.
15. Babb, R.C.; Homer, K.A.; Robbins, J.; Lax, A.J. Modification of heterotrimeric G-proteins in Swiss 3T3 cells stimulated with Pasteurella multocida toxin. PLoS One 2012, 7, e47188.
16. Orth, J.H.; Fester, I.; Preuss, I.; Agnoletto, L.; Wilson, B.A.; Aktories, K. Activation of Galpha (i) and subsequent uncoupling of receptor-Galpha(i) signaling by Pasteurella multocida toxin. J. Biol. Chem. 2008, 283, 23288-23294.
17. Orth, J.H.C.; Aktories, K. Pasteurella multocida toxin activates various heterotrimeric G proteins by deamidation. Toxins 2010, 2, 205-214.
18. Orth, J.H.; Lang, S.; Aktories, K. Action of Pasteurella multocida toxin depends on the helical domain of Galphaq. J. Biol. Chem. 2004, 279, 34150-34155.
19. Preuss, I.; Kurig, B.; Nurnberg, B.; Orth, J.H.; Aktories, K. Pasteurella multocida toxin activates Gbetagamma dimers of heterotrimeric G proteins. Cell. Signal. 2009, 21, 551-558.
20. Wilson, B.A.; Ho, M. Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida. FEBS J. 2011, 278, 4616-4632.
21. Aggarwal, B.B.; Shishodia, S.; Sandur, S.K.; Pandey, M.K.; Sethi, G. Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 2006, 72, 1605-1621.
22. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867.
23. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature 2008, 454, 436-444.
24. Dalton-Griffin, L.; Kellam, P. Infectious causes of cancer and their detection. J. Biol. 2009, 8, 67.
25. Kipanyula, M.J.; Seke Etet, P.F.; Vecchio, L.; Farahna, M.; Nukenine, E.N.; Nwabo Kamdje, A.H. Signaling pathways bridging microbial-triggered inflammation and cancer. Cell. Signal. 2013, 25, 403-416.
26. Lax, A.J.; Thomas, W. How bacteria could cause cancer: One step at a time. Trends Microbiol. 2002, 10, 293-299.
27. Grote, V.A.; Kaaks, R.; Nieters, A.; Tjonneland, A.; Halkjaer, J.; Overvad, K.; Skjelbo Nielsen, M.R.; Boutron-Ruault, M.C.; Clavel-Chapelon, F.; Racine, A.; et al. Inflammation marker and risk of pancreatic cancer: A nested case-control study within the EPIC cohort. Br. J. Cancer 2012, 106, 1866-1874.
28. De Martel, C.; Ferlay, J.; Franceschi, S.; Vignat, J.; Bray, F.; Forman, D.; Plummer, M. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol. 2012, 13, 607-615.
29. Compare, D.; Nardone, G. Contribution of gut microbiota to colonic and extracolonic cancer development. Dig. Dis. 2011, 29, 554-561.
30. Oswald, E.; Nougayrede, J.P.; Taieb, F.; Sugai, M. Bacterial toxins that modulate host cell-cycle progression. Curr. Opin. Microbiol. 2005, 8, 83-91.
31. Lax, A.J. Opinion: Bacterial toxins and cancer-A case to answer? Nat. Rev. Microbiol. 2005, 3, 343-349.
32. Lax, A. The Pasteurella multocida toxin: A new paradigm for the link between bacterial infection and cancer. Curr. Top. Microbiol. Immunol. 2012, 361, 131-144.
33. Hoskins, I.C.; Thomas, L.H.; Lax, A.J. Nasal infection with Pasteurella multocida causes proliferation of bladder epithelium in gnotobiotic pigs. Vet. Rec. 1997, 140, 22.
34. Rozengurt, E.; Higgins, T.; Chanter, N.; Lax, A.J.; Staddon, J.M. Pasteurella multocida toxin: Potent mitogen for cultured fibroblasts. Proc. Natl. Acad. Sci. USA 1990, 87, 123-127.
35. Martineau-Doize, B.; Caya, I.; Gagne, S.; Jutras, I.; Dumas, G. Effects of Pasteurella multocida toxin on the osteoclast population of the rat. J. Comp. Pathol. 1993, 108, 81-91.
36. Nougayrede, J.P.; Taieb, F.; de Rycke, J.; Oswald, E. Cyclomodulins: Bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 2005, 13, 103-110.
37. Orth, J.H.; Aktories, K.; Kubatzky, K.F. Modulation of host cell gene expression through activation of STAT transcription factors by Pasteurella multocida toxin. J. Biol. Chem. 2007, 282, 3050-3057.
38. Seo, B.; Choy, E.W.; Maudsley, S.; Miller, W.E.; Wilson, B.A.; Luttrell, L.M. Pasteurella multocida toxin stimulates mitogen-activated protein kinase via G(q/11)-dependent transactivation of the epidermal growth factor receptor. J. Biol. Chem. 2000, 275, 2239-2245.
39. Yoshimura, A.; Suzuki, M.; Sakaguchi, R.; Hanada, T.; Yasukawa, H. SOCS, inflammation, and autoimmunity. Front. Immunol. 2012, 3, 20.
40. Hildebrand, D.; Walker, P.; Dalpke, A.; Heeg, K.; Kubatzky, K.F. Pasteurella multocida Toxin-induced Pim-1 expression disrupts suppressor of cytokine signaling (SOCS)-1 activity. Cell. Microbiol. 2010, 12, 1732-1745.
41. Grivennikov, S.; Karin, E.; Terzic, J.; Mucida, D.; Yu, G.Y.; Vallabhapurapu, S.; Scheller, J.; Rose-John, S.; Cheroutre, H.; Eckmann, L.; et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009, 15, 103-113.
42. Chen, J.L.; Limnander, A.; Rothman, P.B. Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene. Blood 2008, 111, 1677-1685.
43. Limnander, A.; Danial, N.N.; Rothman, P.B. v-Abl signaling disrupts SOCS-1 function in transformed pre-B cells. Mol. Cell. 2004, 15, 329-341.
44. Al-Haddawi, M.H.; Jasni, S.; Zamri-Saad, M.; Mutalib, A.R.; Son, R.; Sheikh-Omar, A.R. Ultrastructural observation of nasal and pulmonary intracellular Pasteurella multocida A:3 in rabbits. Vet. Res. Commun. 2000, 24, 153-167.
45. Al-haj Ali, H.; Sawada, T.; Hatakeyama, H.; Katayama, Y.; Ohtsuki, N.; Itoh, O. Invasion of chicken embryo fibroblast cells by avian Pasteurella multocida. Vet. Microbiol. 2004, 104, 55-62.
46. Galdiero, M.; de Martino, L.; Pagnini, U.; Pisciotta, M.G.; Galdiero, E. Interactions between bovine endothelial cells and Pasteurella multocida: Association and invasion. Res. Microbiol. 2001, 152, 57-65.
47. Hundt, M.J.; Ruffolo, C.G. Interaction of Pasteurella multocida with free-living amoebae. Appl. Environ. Microbiol. 2005, 71, 5458-5464.
48. Othman, S.; Parton, R.; Coote, J. Interaction between mammalian cells and Pasteurella multocida B:2. Adherence, invasion and intracellular survival. Microbial. Pathog. 2012, 52, 353-358.
49. Rabier, M.J.; Tyler, N.K.; Walker, N.J.; Hansen, L.M.; Hirsh, D.C.; Tablin, F. Pasteurella multocida enters polarized epithelial cells by interacting with host F-actin. Vet. Microbiol. 1997, 54, 343-355.
50. Lee, M.D.; Wooley, R.E.; Glisson, J.R. Invasion of epithelial cell monolayers by turkey strains of Pasteurella multocida. Avian Dis. 1994, 38, 72-77.
51. Nawijn, M.C.; Alendar, A.; Berns, A. For better or for worse: The role of Pim oncogenes in tumorigenesis. Nat. Rev. Cancer 2011, 11, 23-34.
52. Preuss, I.; Hildebrand, D.; Orth, J.H.; Aktories, K.; Kubatzky, K.F. Pasteurella multocida toxin is a potent activator of anti-apoptotic signaling pathways. Cell. Microbiol. 2010, 12, 1174-1185.
53. Nagase, Y.; Iwasawa, M.; Akiyama, T.; Kadono, Y.; Nakamura, M.; Oshima, Y.; Yasui, T.; Matsumoto, T.; Hirose, J.; Nakamura, H.; et al. Anti-apoptotic molecule Bcl-2 regulates the differentiation, activation, and survival of both osteoblasts and osteoclasts. J. Biol. Chem. 2009, 284, 36659-36669.
54. Yamashita, J.; Datta, N.S.; Chun, Y.H.; Yang, D.Y.; Carey, A.A.; Kreider, J.M.; Goldstein, S.A.; McCauley, L.K. Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone. J. Bone Miner. Res. 2008, 23, 621-632.
55. Faustin, B.; Chen, Y.; Zhai, D.; le Negrate, G.; Lartigue, L.; Satterthwait, A.; Reed, J.C. Mechanism of Bcl-2 and Bcl-X(L) inhibition of NLRP1 inflammasome: Loop domain-dependent suppression of ATP binding and oligomerization. Proc. Natl. Acad. Sci. USA 2009, 106, 3935-3940.
56. Bruey, J.M.; Bruey-Sedano, N.; Luciano, F.; Zhai, D.; Balpai, R.; Xu, C.; Kress, C.L.; Bailly-Maitre, B.; Li, X.; Osterman, A.; et al. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007, 129, 45-56.
57. Oubrahim, H.; Wong, A.; Wilson, B.A.; Chock, P.B. Mammalian target of rapamycin complex 1 (mTORC1) plays a role in Pasteurella multocida toxin (PMT)-induced protein synthesis and proliferation in Swiss 3T3 cells. J. Biol. Chem. 2013, 288, 2805-2815.
58. Alayev, A.; Holz, M.K. mTOR signaling for biological control and cancer. J. Cell. Physiol. 2013, 228, 1658-1664.
59. Thiem, S.; Pierce, T.P.; Palmieri, M.; Putoczki, T.L.; Buchert, M.; Preaudet, A.; Farid, R.O.; Love, C.; Catimel, B.; Lei, Z.; et al. mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. J. Clin. Invest. 2013, 123, 767-781.
60. Zoncu, R.; Efeyan, A.; Sabatini, D.M. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell. Biol. 2011, 12, 21-35.
61. Oubrahim, H.; Wong, A.; Wilson, B.A.; Chock, P.B. Pasteurella multocida toxin (PMT) upregulates CTGF which leads to mTORC1 activation in Swiss 3T3 cells. Cell. Signal. 2013, 25, 1136-1148.
62. Kular, L.; Pakradouni, J.; Kitabgi, P.; Laurent, M.; Martinerie, C. The CCN family: A new class of inflammation modulators? Biochimie 2011, 93, 377-388.
63. Cheville, N.F.; Rimler, R.B. A protein toxin from Pasteurella multocida type D causes acute and chronic hepatic toxicity in rats. Vet. Pathol. 1989, 26, 148-157.
64. Al-Haddawi, M.H.; Jasni, S.; Israf, D.A.; Zamri-Saad, M.; Mutalib, A.R.; Sheikh-Omar, A.R. Ultrastructural pathology of nasal and tracheal mucosa of rabbits experimentally infected with Pasteurella multocida serotype D:1. Res. Vet. Sci. 2001, 70, 191-197.
65. Hildebrand, D.; Heeg, K.; Kubatzky, K.F. Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent. Infect. Immun. 2011, 79, 220-228.
66. Hildebrand, D.; Sahr, A.; Wolfle, S.J.; Heeg, K.; Kubatzky, K.F. Regulation of Toll-like receptor 4-mediated immune responses through Pasteurella multocida toxin-induced G protein signaling. Cell. Commun. Signal. 2012, 10, 22.
67. Wolfle, S.J.; Strebovsky, J.; Bartz, H.; Sahr, A.; Arnold, C.; Kaiser, C.; Dalpke, A.H.; Heeg, K. PD-L1 expression on tolerogenic APCs is controlled by STAT-3. Eur. J. Immunol. 2011, 41, 413-424.
68. Janeway, C.A., Jr.; Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20, 197-216.
69. Guha, M.; Mackman, N. LPS induction of gene expression in human monocytes. Cell. Signal. 2001, 13, 85-94.
70. Schmittel, A.; Scheibenbogen, C.; Keilholz, U. Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocytes. Scand. J. Immunol. 1995, 42, 701-704.
71. Bagley, K.C.; Abdelwahab, S.F.; Tuskan, R.G.; Fouts, T.R.; Lewis, G.K. Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway. Infect. Immun. 2002, 70, 5533-5539.
72. Braun, M.C.; Kelsall, B.L. Regulation of interleukin-12 production by G-protein-coupled receptors. Microbes Infect. 2001, 3, 99-107.
73. Bagley, K.C.; Abdelwahab, S.F.; Tuskan, R.G.; Lewis, G.K. Pasteurella multocida toxin activates human monocyte-derived and murine bone marrow-derived dendritic cells in vitro but suppresses antibody production in vivo. Infect. Immun. 2005, 73, 413-421.
74. Trinchieri, G. Interleukin-12: A cytokine at the interface of inflammation and immunity. Adv. Immunol. 1998, 70, 83-243.
75. Kubin, M.; Kamoun, M.; Trinchieri, G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 1994, 180, 211-222.
76. Wolf, S.F.; Temple, P.A.; Kobayashi, M.; Young, D.; Dicig, M.; Lowe, L.; Dzialo, R.; Fitz, L.; Ferenz, C.; Hewick, R.M.; et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 1991, 146, 3074-3081.
77. Blocker, D.; Berod, L.; Fluhr, J.W.; Orth, J.; Idzko, M.; Aktories, K.; Norgauer, J. Pasteurella multocida toxin (PMT) activates RhoGTPases, induces actin polymerization and inhibits migration of human dendritic cells, but does not influence macropinocytosis. Int. Immunol. 2006, 18, 459-464.
78. Banchereau, J.; Steinman, R.M. Dendritic cells and the control of immunity. Nature 1998, 392, 245-252.
79. Aktories, K.; Schwan, C.; Papatheodorou, P.; Lang, A.E. Bidirectional attack on the actin cytoskeleton. Bacterial protein toxins causing polymerization or depolymerization of actin. Toxicon 2012, 60, 572-581.
80. Barbieri, J.T.; Riese, M.J.; Aktories, K. Bacterial toxins that modify the actin cytoskeleton. Annu. Rev. Cell Dev. Biol. 2002, 18, 315-344.
81. Van Diemen, P.M.; de Vries Reilingh, G.; Parmentier, H.K. Immune responses of piglets to Pasteurella multocida toxin and toxoid. Vet. Immunol. Immunopathol. 1994, 41, 307-321.
82. Bording, A.; Foged, N.T. Characterization of the immunogenicity of formaldehyde detoxified Pasteurella multocida toxin. Vet. Microbiol. 1991, 29, 267-280.
83. Suckow, M.A.; Bowersock, T.L.; Nielsen, K.; Chrisp, C.E.; Frandsen, P.L.; Janovitz, E.B. Protective immunity to Pasteurella multocida heat-labile toxin by intranasal immunization in rabbits. Lab. Anim. Sci. 1995, 45, 526-532.
84. To, H.; Someno, S.; Nagai, S. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs. Am. J. Vet. Res. 2005, 66, 113-118.
85. Arron, J.R.; Choi, Y. Bone versus immune system. Nature 2000, 408, 535-536.
86. Takayanagi, H. New developments in osteoimmunology. Nat. Rev. Rheumatol. 2012, 8, 684-689.
87. Kamp, E.M.; Kimman, T.G. Induction of nasal turbinate atrophy in germ-free pigs, using Pasteurella multocida as well as bacterium-free crude and purified dermonecrotic toxin of P. multocida. Am. J. Vet. Res. 1988, 49, 1844-1849.
88. Jutras, I.; Martineau-Doize, B. Stimulation of osteoclast-like cell formation by Pasteurella multocida toxin from hemopoietic progenitor cells in mouse bone marrow cultures. Can. J. Vet. Res. 1996, 60, 34-39.
89. Gwaltney, S.M.; Galvin, R.J.; Register, K.B.; Rimler, R.B.; Ackermann, M.R. Effects of Pasteurella multocida toxin on porcine bone marrow cell differentiation into osteoclasts and osteoblasts. Vet. Pathol. 1997, 34, 421-430.
90. Mullan, P.B.; Lax, A.J. Pasteurella multocida toxin stimulates bone resorption by osteoclasts via interaction with osteoblasts. Calcif. Tissue Int. 1998, 63, 340-345.
91. Sterner-Kock, A.; Lanske, B.; Uberschar, S.; Atkinson, M.J. Effects of the Pasteurella multocida toxin on osteoblastic cells in vitro. Vet. Pathol. 1995, 32, 274-279.
92. Mullan, P.B.; Lax, A.J. Pasteurella multocida toxin is a mitogen for bone cells in primary culture. Infect. Immun. 1996, 64, 959-965.
93. Siegert, P.; Schmidt, G.; Papatheodorou, P.; Wieland, T.; Aktories, K.; Orth, J.H. Pasteurella multocida toxin prevents osteoblast differentiation by transactivation of the MAP-kinase cascade via the Galpha(q/11)-p63RhoGEF-RhoA axis. PLoS Pathog. 2013, 9, e1003385.
94. Suganami, T.; Tanaka, M.; Ogawa, Y. Adipose tissue inflammation and ectopic lipid accumulation. Endocr. J. 2012, 59, 849-857.
95. Fresno, M.; Alvarez, R.; Cuesta, N. Toll-like receptors, inflammation, metabolism and obesity. Arch. Physiol. Biochem. 2011, 117, 151-164.
96. Marie, P.J. Transcription factors controlling osteoblastogenesis. Arch. Biochem. Biophys. 2008, 473, 98-105.
97. Orth, J.H.; Lang, S.; Taniguchi, M.; Aktories, K. Pasteurella multocida toxin-induced activation of RhoA is mediated via two families of G{alpha} proteins, G{alpha}q and G{alpha}12/13. J. Biol. Chem. 2005, 280, 36701-36707.
98. Harmey, D.; Stenbeck, G.; Nobes, C.D.; Lax, A.J.; Grigoriadis, A.E. Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): A role for Rho GTPase in bone formation. J. Bone Miner. Res. 2004, 19, 661-670.
99. Haniffa, M.A.; Collin, M.P.; Buckley, C.D.; Dazzi, F. Mesenchymal stem cells: The fibroblasts' new clothes? Haematologica 2009, 94, 258-263.
100. Ren, G.; Zhang, L.; Zhao, X.; Xu, G.; Zhang, Y.; Roberts, A.I.; Zhao, R.C.; Shi, Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell. Stem Cell 2008, 2, 141-150.
101. Flavell, S.J.; Hou, T.Z.; Lax, S.; Filer, A.D.; Salmon, M.; Buckley, C.D. Fibroblasts as novel therapeutic targets in chronic inflammation. Br. J. Pharmacol. 2008, 153, S241-S246.